Protocol for Controlling the Strand Selectivity of siRNA Using Acyclic Artificial Nucleic Acids

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Small interfering RNA (siRNA) holds promise for treating diseases.
• Optimizing siRNA requires balancing high on-target activity with minimized off-target effects.
• Acyclic artificial nucleic acids, like serinol nucleic acids (SNA), show potential in enhancing siRNA selectivity.

Purpose of the Study:

• To provide guidelines for designing SNA-modified siRNA.
• To outline methods for experimentally evaluating the on-target and off-target activities of siRNAs.
• To ensure accurate functional validation of siRNA therapeutics in cellular systems.

Main Methods:

• Design of SNA-modified siRNA sequences.
• Preparation of vector plasmids using inverse PCR or restriction enzymes and ligase.
• Evaluation of siRNA on-target and off-target effects using a dual-luciferase assay.

Main Results:

• SNA modification demonstrates potential for enhancing siRNA selectivity.
• Protocols are established for designing and validating SNA-modified siRNAs.
• The methods facilitate accurate assessment of on-target and off-target activities.

Conclusions:

• SNA-modified siRNA offers a strategy to optimize siRNA selectivity and efficacy.
• Minimizing off-target effects is crucial for developing effective siRNA therapeutics.
• These design and validation strategies benefit researchers in the field of siRNA-based therapeutics.